RxDoctor Payments Data

Nate Milburn, MD

Internal Medicine · Dallas, TXNPI 1558802868

Payments from drug & device makers

$7,188in general payments, 2019–2025

Across 25 payments — averaging $287.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Trice Medical, Inc.$7K
  • Ferring Pharmaceuticals Inc.$181
  • Bioventus LLC$154
  • Merck$17

What the payments were for

  • Consulting fees$5,10071%
  • Travel & lodging$1,08615%
  • Food & beverage$1,00214%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,188 in reported general payments places this provider in the 90th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas

Medicare billing

Part B allowed, 2024
$428,090
Medicare patients
1,230
Services billed
20,631

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium115$1,134
Celecoxib11$215
Methylprednisolone23$147
Meloxicam16$131
Prednisone16$38

Paid to pharmacies, not to this prescriber.

Other internal medicine in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →